Resistance to endotoxin shock in transgenic mice overexpressing endothelial nitric oxide synthase.
- 29 February 2000
- journal article
- other
- Published by Ovid Technologies (Wolters Kluwer Health) in Circulation
- Vol. 101 (8), 931-937
- https://doi.org/10.1161/01.cir.101.8.931
Abstract
Background —Nitric oxide (NO) plays a central role in the pathogenesis of septic shock. However, the role of the NO produced by endothelial NO synthase (eNOS) in septic shock is still unclear. We examined the effect of chronic eNOS overexpression and the role of eNOS-derived NO in lipopolysaccharide (LPS)-induced septic shock using eNOS transgenic (Tg) mice. Methods and Results —LPS was intraperitoneally injected into Tg and control mice. No differences existed in the peak plasma nitrate and nitrate levels induced by LPS between the 2 genotypes. In LPS-treated control mice, blood pressure progressively declined and reached 60% of basal levels (from 97±3 to 59±3 mm Hg) 24 hours after LPS injection. In contrast, the blood pressure of LPS-treated Tg mice fell only 15% from basal levels (from 84±4 to 71±4 mm Hg) after the first 6 hours and, thereafter, it remained at this level. LPS-induced increases in the expression of the mRNA of both vascular cell adhesion molecule-1 and intracellular adhesion molecule-1 in the lungs were significantly lower in Tg mice than in control mice. LPS-induced pulmonary leukocyte infiltration and increases in lung water content were also significantly attenuated in Tg mice. Histological examination revealed that lung injury after LPS injection was milder in Tg mice. Furthermore, Tg mice exhibited enhanced survival from LPS-induced septic shock compared with control mice. Conclusions —Chronic eNOS overexpression in the endothelium of mice resulted in resistance to LPS-induced hypotension, lung injury, and death. These effects are associated with the reduced vascular reactivity to NO and the reduced anti-inflammatory effects of NO.This publication has 16 references indexed in Scilit:
- Hypotension and reduced nitric oxide-elicited vasorelaxation in transgenic mice overexpressing endothelial nitric oxide synthase.JCI Insight, 1998
- Elevated blood pressures in mice lacking endothelial nitric oxide synthaseProceedings of the National Academy of Sciences of the United States of America, 1996
- Mice lacking inducible nitric oxide synthase are not resistant to lipopolysaccharide-induced death.Proceedings of the National Academy of Sciences of the United States of America, 1995
- Altered responses to bacterial infection and endotoxic shock in mice lacking inducible nitric oxide synthaseCell, 1995
- Beneficial effects and improved survival in rodent models of septic shock with S-methylisothiourea sulfate, a potent and selective inhibitor of inducible nitric oxide synthase.Proceedings of the National Academy of Sciences of the United States of America, 1994
- The L-Arginine-Nitric Oxide PathwayThe New England Journal of Medicine, 1993
- Cloning and sequencing of mouse VCAM-1 cDNAGene, 1993
- Cytokine‐induced expression of an inducible type of nitric oxide synthase gene in cultured vascular smooth muscle cellsFEBS Letters, 1993
- N omega-amino-L-arginine, an inhibitor of nitric oxide synthase, raises vascular resistance but increases mortality rates in awake canines challenged with endotoxin.The Journal of Experimental Medicine, 1992
- Sequence and expression of rat ICAM-1Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression, 1992